住院患者严重酒精戒断综合征管理的研究需求:美国胸科学会官方研究声明
该美国胸科学会官方研究声明聚焦住院患者严重酒精戒断综合征(SAWS)的管理。委员会在2019年美国胸科学会国际会议期间组织研讨会,由医学图书馆员进行实用性文献检索,按T0-T1、T2、T3、T4四个转化科学领域分组梳理已知证据与知识缺口。主要主题包括:探索非γ-氨基丁酸通路治疗酒精戒断综合征、利用回顾性与电子健康记录数据识别危险因素并建立客观严重度评分(尤其针对急重症SAWS患者)、需要更稳健的比较有效性数据以确定最佳SAWS治疗策略、以及加速有效治疗落地实践。结论强调支持住院SAWS患者管理决策的证据匮乏,呼吁美国胸科学会及更广泛科学界开展基础、临床与实施研究。
要点
- 住院患者SAWS管理证据极度匮乏,该声明按T0-T4转化科学连续体逐域列出研究缺口。
- 研究重点包括探索非γ-氨基丁酸通路用于酒精戒断综合征治疗。
- 建议利用回顾性与电子健康记录数据识别危险因素、建立客观严重度评分系统,尤其针对急重症SAWS患者。
- 需要更稳健的比较有效性数据以确定最佳SAWS治疗策略。
- 声明提出加速有效治疗转化为实践的建议。
适用人群与场景
- 住院患者中发生严重酒精戒断综合征(SAWS)者,其中许多人需要重症监护。
研究设计与关键结果
- 美国胸科学会组织基础、临床与实施研究领域专家,在2019年美国胸科学会国际会议期间召开研讨会,按T0-T1、T2、T3、T4四个转化科学领域分组,由医学图书馆员进行实用性文献检索,委员会成员审阅并补充证据、识别关键知识缺口。
- 主要主题包括:研究非γ-氨基丁酸通路用于酒精戒断综合征治疗;利用回顾性与电子健康记录数据识别危险因素并建立客观严重度评分系统,尤其针对急重症SAWS患者;需要更稳健的比较有效性数据以确定最佳SAWS治疗策略;提出加速有效治疗落地实践的建议。
证据类型、等级与局限
- 证据类型:美国胸科学会官方研究声明(专家委员会基于实用性文献检索的共识文件)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 声明指出支持住院SAWS患者管理决策的证据匮乏,呼吁美国胸科学会及更广泛科学界开展基础、临床与实施研究以改善这一脆弱人群的照护。
指南或共识出处
- 美国胸科学会官方研究声明《Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome》,发表于American Journal of Respiratory and Critical Care Medicine。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Background: Severe alcohol withdrawal syndrome (SAWS) is highly morbid, costly, and common among hospitalized patients, yet minimal evidence exists to guide inpatient management. Research needs in this field are broad, spanning the translational science spectrum. Goals: This research statement aims to describe what is known about SAWS, identify knowledge gaps, and offer recommendations for research in each domain of the Institute of Medicine T0-T4 continuum to advance the care of hospitalized patients who experience SAWS. Methods: Clinicians and researchers with unique and complementary expertise in basic, clinical, and implementation research related to unhealthy alcohol consumption and alcohol withdrawal were invited to participate in a workshop at the American Thoracic Society 2019 International Conference. The committee was subdivided into four groups on the basis of interest and expertise: T0-T1 (basic science research with translation to humans), T2 (research translating to patients), T3 (research translating to clinical practice), and T4 (research translating to communities). A medical librarian conducted a pragmatic literature search to facilitate this work, and committee members reviewed and supplemented the resulting evidence, identifying key knowledge gaps. Results: The committee identified several investigative opportunities to advance the care of patients with SAWS in each domain of the translational science spectrum. Major themes included 1) the need to investigate non-γ-aminobutyric acid pathways for alcohol withdrawal syndrome treatment; 2) harnessing retrospective and electronic health record data to identify risk factors and create objective severity scoring systems, particularly for acutely ill patients with SAWS; 3) the need for more robust comparative-effectiveness data to identify optimal SAWS treatment strategies; and 4) recommendations to accelerate implementation of effective treatments into practice. Conclusions: The dearth of evidence supporting management decisions for hospitalized patients with SAWS, many of whom require critical care, represents both a call to action and an opportunity for the American Thoracic Society and larger scientific communities to improve care for a vulnerable patient population. This report highlights basic, clinical, and implementation research that diverse experts agree will have the greatest impact on improving care for hospitalized patients with SAWS.
参考来源
- Steel TL, Afshar M, Edwards S, et al. Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2021. PMID: 34609257. doi:10.1164/rccm.202108-1845ST
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。